遗传资源的专利权
R. Stephen Crespi,童诚
摘要(Abstract)：
虽然专利法对于包括科学家在内的许多人来说是一块无人区,但近年由于生物技术的冲击,已变得开放得多。生物技术创新提出了许多使法律感到棘手的问题,特别是关于活有机体的问题,而最近20年则为任何准备在这个领域奉法行事的人。提供了值得注意的文化经验。给遗传材料专利权是一个高度现实的问题,为法律和技术以外的许多人所渴望,但又是一个只对照下述更广泛背景才能充分理解的问题。
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): R. Stephen Crespi,童诚
参考文献(References)：
- 1． LouiS Pasteur;US patent 141,072 of 22 July 1873．
- 2． Funk Bros Seed Co.v Kalo Inoculant Co.76 United states Patent Quarterly(USPQ)280．
- 3． Diamond v Chakrgbarty 206 USPO 193:US Patent 4,259,444．
- 4． Ex parte Hibberd 227 USPQ 443．
- 5． USPTO policy statement. Commissioner of Patents, 4 July 1987．
- 6． 'Harvard Mouse', The President and Fellows of Harvard College; US patent 3,736,866．
- 7． European Patent Convention. Article 53 (b).
- 8． Lubrizol Genetics Inc. Official Journal of the European Patent Office, March 1990, 59-62．
- 9． S. N. Cohen and H. W. Boyer: US patents 4,237,224 and 4,339,538．
- 10． European Patent Office Guidelines, Part C. Chapter Ⅳ, 2． 1．
- 11． European Commission Proposal For a Directive on the Legal Protection of Biotechnolog ical Inventions, Communication 496, final SYN 159． Brussels, 17 October 1988．
- 12． Eli Lilly Co.; US patent 4． 885． 251．
- 13． Agricultural Genetics Co.: UK patent 2,165,261．
- 14． Monsanto: European patent applications 269． 601 and 289,479．
- 15． Agricultural Genetics Co.; European patent application 272,144．
- 16． Commission on Plant Genetic Resources, Report of Third Session, Rome, 17-20 April 1989．
- 17． Howard Hughes Medical Institute: European patent application 256,630．
- 18． Collaborative Research Inc.: European patent application 226,288．